Articles Tagged With: frostbite
-
Iloprost Injection (Aurlumyn)
The U.S. Food and Drug Administration has approved iloprost for the treatment of severe frostbite to reduce the risk of amputation of fingers or toes. Iloprost, a synthetic analog of prostaglandin, initially was approved in 2004 for the treatment of pulmonary arterial hypertension. For that indication, it was given a priority review, accelerated approval, breakthrough therapy, and orphan drug designations. Iloprost for the frostbite indication is distributed by Eicos Sciences as Aurlumyn.
-
Evaluation and Management of Burn Injuries
Although burn injuries are seen less frequently then they used to be, it is still critical for the acute care provider to stay current on best practices for the care of the burn patient. The authors provide an update on the evaluation and management of burn injuries.
-
Hypothermia and Frostbite
All emergency providers should be familiar with hypothermia regardless of the climate in which they practice. Hypothermia can occur in a variety of climates, indoors or outdoors, and in patients of all ages regardless of health status. Frostbite, chilblains, trench foot, and cold urticaria are cold-related injuries that may present to any emergency department during any time of year.